We are live on ! Find out more
PMN icon

ProMIS Neurosciences
PMN

17 hedge funds and large institutions have $9.21M invested in ProMIS Neurosciences in 2024 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 17 → 17 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

0.16% less ownership

Funds ownership: 1.35% → 1.19% (-0.16%)

27% less capital invested

Capital invested by funds: $12.6M → $9.21M (-$3.4M)

80% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 5

Holders
17
Holders Change
–
Holders Change %
0%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
5
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$4.71K

Top Sellers

Rank Fund Capital Flow
1
HCM
Heights Capital Management
California
-$226K
2
AC
Armistice Capital
New York
-$159K
3
GPP
Great Point Partners
Connecticut
-$145K
4
AAA
Affinity Asset Advisors
New York
-$38.3K
5
FT
Fiduciary Trust
Massachusetts
-$6.4K

PMN Hedge Fund Activity: Q4 2024 in Review

17 of the 7,607 institutional investors tracked by Wall St. Rank reported a position in ProMIS Neurosciences (PMN) for Q4 2024, worth a combined $9.21M — down 27% from $12.6M a quarter earlier.

Fund positioning in PMN was balanced in Q4 2024: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 5 trimmed.

The largest buyer was Royal Bank of Canada, adding an estimated $4.71K. The largest seller was Heights Capital Management, cutting an estimated $226K.

  • 17 institutional investors held ProMIS Neurosciences (PMN) as of Q4 2024, unchanged from Q3 2024.
  • Funds reported $9.21M of ProMIS Neurosciences stock for Q4 2024, down 27% quarter-over-quarter.
  • 1 fund opened new ProMIS Neurosciences positions in Q4 2024 and 1 closed out, a net change of 0 holders.
  • The largest ProMIS Neurosciences buyer in Q4 2024 was Royal Bank of Canada, an estimated $4.71K added.
  • The largest ProMIS Neurosciences seller in Q4 2024 was Heights Capital Management, an estimated $226K sold.

Based on aggregated 13F filings for Q4 2024.